AG

Aradhana Gaur

Active Director Director DIN 07982967
DIN 07982967 First appointment Dec 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Dec 2017
Shareholding value •••• Premium profile

About Aradhana Gaur

Data last updated:

Aradhana Gaur is a Director at Swear Healthcare Private Limited (since 2017), Director at Dhanshah Healthcare Private Limited (since 2021) and Director at Trimaya Healthcare Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Home Appliances. The 4 current companies with reported revenue have a combined latest revenue of ₹57.30 Cr; the largest is Swear Healthcare Private Limited at ₹52.49 Cr (FY 2024). Earlier, Aradhana Gaur was a Director at Musk Finlease Private Limited (from 2018).

DIN 07982967
Primary Designation Director
Industry Healthcare
First Appointment 28 Dec 2017
Oldest Company Age 29 yrs
Largest company Swear Healthcare Private Limited · ₹52.49 Cr (FY 2024)
Combined revenue ₹57.30 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Swear Healthcare Private Limited U33110UP2014PTC064405
Director28 Dec 20172014₹52.49 Cr (FY 2024)Active
Dhanshah Healthcare Private Limited U24290RJ2021PTC076224
Director03 Aug 20212021₹3.57 Cr (FY 2025)Active
Trimaya Healthcare Private Limited U33100HR2021PTC096847
Director01 Jan 20252021₹1.21 Cr (FY 2024)Active
Sirealism Private Limited U52100HR2021PTC096913
Director09 Aug 20212021₹3.1 Lakh (FY 2025)Active
Trasaya Healthcare Private Limited U33100RJ2021PTC076305
Director05 Aug 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Musk Finlease Private Limited U65910DL1996PTC083715
Director05 May 20181996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Aradhana Gaur

Directorship timeline

Open interactive timeline →
Dhanshah Healthcare Private Limited
Trasaya Healthcare Private Limited
Swear Healthcare Private Limited
Sirealism Private Limited
Premium access

Shareholding and investment profile for Aradhana Gaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aradhana Gaur

Aradhana Gaur currently holds 5 directorships: Swear Healthcare Private Limited (Director, since 28 Dec 2017, revenue ₹52.49 Cr (FY 2024)); Dhanshah Healthcare Private Limited (Director, since 03 Aug 2021, revenue ₹3.57 Cr (FY 2025)); Trimaya Healthcare Private Limited (Director, since 01 Jan 2025, revenue ₹1.21 Cr (FY 2024)); Sirealism Private Limited (Director, since 09 Aug 2021, revenue ₹3.1 Lakh (FY 2025)); Trasaya Healthcare Private Limited (Director, since 05 Aug 2021).

Aradhana Gaur was first appointed on 28 Dec 2017 as Director at Swear Healthcare Private Limited. The most recent appointment on record is 01 Jan 2025 at Trimaya Healthcare Private Limited.

The 4 current companies of Aradhana Gaur that report revenue have a combined latest revenue of ₹57.30 Cr: Swear Healthcare Private Limited ₹52.49 Cr (FY 2024); Dhanshah Healthcare Private Limited ₹3.57 Cr (FY 2025); Trimaya Healthcare Private Limited ₹1.21 Cr (FY 2024); Sirealism Private Limited ₹3.1 Lakh (FY 2025).

Aradhana Gaur held 1 earlier board appointment: Musk Finlease Private Limited (Director, from 05 May 2018).

The current boards of Aradhana Gaur's companies include Sanjeev Gaur (Swear Healthcare Private Limited), Prerana Gaur (Sirealism Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available